Pharmacokinetics of the Protease Inhibitor Indinavir in Human Immunodeficiency Virus Type 1-Infected Children

The objective of this study was to evaluate the pharmacokinetics of indinavir in human immunodeficiency virus-infected children as part of a prospective, open, uncontrolled, multicenter study in The Netherlands. Human immunodeficiency virus type 1-infected children were monitored over 6 months of tr...

Descrición completa

Detalles Bibliográficos

Publicado en:	Antimicrob Agents Chemother
Principais autores:	Burger, David M., van Rossum, Annemarie M. C., Hugen, Patricia W. H., Suur, Marja H., Hartwig, Nico G., Geelen, Sibyl P. M., Scherpbier, Henriette J., Hoetelmans, Richard M. W., Vulto, Arnold G., de Groot, Ronald
Formato:	Artigo
Idioma:	Inglês
Publicado:	American Society for Microbiology (ASM) 2001
Assuntos:	Pharmacology
Acceso en liña:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC90359/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11181346/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.45.3.701-705.2001
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!